Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|January 30, 2025
Development of a Highly Selective Ferroptosis Inducer Targeting GPX4 with 2-Ethynylthiazole-4-carboxamide as Electrophilic WarheadSunkai Gu, Guanyu Yang, Hongyuan Bian, et al.
Journal of Natural Products|March 2, 2026
Spiroeutypetides A and B, Polyketides with 5/6/5 and 6/6/5 Tricyclic Ring Systems Produced by the Marine-Derived Fungus Eutypella sp. F0219Qing-Xia Huang, Jing Zhou, Ming-Bin Chen, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 8, 2023
A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome-Drug Interaction and Guiding Therapeutic DecisionsDi-Wei Zheng, Ji-Yan Qiao, Jun-Chi Ma, et al.
Journal of Medicinal Chemistry|November 18, 2015
Synthesis and Biological Evaluation of Novel Bouchardatine Derivatives as Potential Adipogenesis/Lipogenesis Inhibitors for Antiobesity TreatmentYong Rao, Hong Liu, Lin Gao, et al.
Phytochemistry|May 2, 2024
Ent-eudesmane sesquiterpenoids with anti-neuroinflammatory activity from the marine-derived fungus Eutypella sp. F0219Zhong-Ping Jiang, Rui Su, Meng-Ting Chen, et al.
British Journal of Pharmacology|May 22, 2019
Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activityYong Rao, Yu-Ting Lu, Chan Li, et al.
Gut Microbes|May 25, 2021
Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axisYong Rao, Zhiqi Kuang, Chan Li, et al.
ACS Nano|December 23, 2024
Cationic Magnetic Nanoparticles Activate Natural Killer Cells for the Treatment of GlioblastomaZhi-Yong Rao, Jing Kuang, Ting Pan, et al.
Free Radical Biology & Medicine|September 19, 2024
Natural linoleic acid from marine fungus Eutypella sp. F0219 blocks KEAP1/NRF2 interaction and ameliorates MASLD by targeting FABP4Chen-Yan Wu, Yue Chen, Meng-Ting Chen, et al.
Pharmacological Research|July 11, 2024
Amplifying hepatic L-aspartate levels suppresses CCl4-induced liver fibrosis by reversing glucocorticoid receptor β-mediated mitochondrial malfunctionRui Su, Hui-Ling Fu, Qian-Xue Zhang, et al.
Pageof 13